Cypre Inc.
Biotechnology ResearchCalifornia, United States2-10 Employees
Cypre is a biotechnology company developing tumor organoid platforms to enable more predictive oncology. Our 3D organoids incorporate tumor, stromal, and immune components in high-throughput formats, built to replace animal models and better capture complex mechanisms of action (MOA). Cypre’s platform supports immunotherapy development through functional insight, MOA analytics, and emerging biomarker discovery, accelerating the path toward precision medicine.